Evidence map›Paper›PMID 38619029›Full record

ArticleArchives of Iranian medicine2024

Gut-Lung Microbiota Characterization in Patients with Non-Small Cell Lung Carcinoma and COVID-19 Coinfection.

Bahareh Vakili, Parisa Shoaei, Kiana Shahzamani, Seyed Davar Siadat, Hasan Shojaei, Zahra Esfandiari, Elahe Nasri, Shiva Shabani, Ali Zamani Moghadam, Behrooz Ataei

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Iranian medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Bahareh VakiliInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-4324-318X
Parisa ShoaeiNosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-7541-422X
Kiana ShahzamaniHepatitis Research Center, School of Medicine, Lorestan University of Medical Sciences, Khoramabad, Iran.ORCID 0000-0002-7485-6034
Seyed Davar SiadatDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0002-6892-5603
Hasan ShojaeiDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0003-1666-9780
Zahra EsfandiariDepartment of Food Science and Technology, Nutrition and Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0003-2399-2762
Elahe NasriInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0001-9963-7084
Shiva ShabaniDepartment of Infectious Diseases, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0003-3911-8404
Ali Zamani MoghadamInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Behrooz AtaeiInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-0763-2786
Isfahan University of Medical Sciences · IRArak University of Medical Sciences · IRLorestan University of Medical Sciences · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-small cell lung cancer (NSCLC) patients with COVID-19 have an excessive chance of morbidity and mortality. The fecal-nasopharyngeal microbiota compositions of NSCLC patients were assessed in this study.

methodsIn total, 234 samples were collected from 17 NSCLC patients infected with COVID-19, 20 NSCLC patients without confirmed COVID-19, 40 non NSCLC patients with COVID-19, and 40 healthy individuals.

resultsIn lung microbiota, the abundance of

conclusionEventually, it was found that compared to control groups, COVID-19 patients with NSCLC showed diminished gut bacteria diversity and increase in

Indexed as

Carcinoma, Non-Small-Cell LungCoinfectionCOVID-19Lung NeoplasmsMicrobiotaHumansLungCOVID-19Gut-lung microbiotaMolecular characterizationNon-small cell lung cancerReal-time PCR

Identifiers

PMID38619029
PMCPMC11017262
OpenAlexW4394583617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.